The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 17, Issue 1, 2011, Pages 27-29

  Walker, Richard W ^a   Howells, Anna R ^b   Gray, William K ^a  

^a NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dyskinesia; Levodopa; Motor fluctuations; Parkinson's disease

Indexed keywords

CABERGOLINE; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATIENT ASSESSMENT; PREDICTION; PREVALENCE; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIAS; FEMALE; HUMANS; LEVODOPA; LOGISTIC MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROGNOSIS;

EID: 78651111843     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.10.005     Document Type: Article

References (20)

1. Fahn S., Oakes D., Shoulson I., Kieburtz K., Rudolph A., Lang A., et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004, 351:2498-2508.
2. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005, 20(Suppl. 11):S11-S16.
3. Obeso J.A., Olanow C.W., Nutt J.G. Levodopa motor complications in Parkinson's disease. Trends Neurosci 2000, 23(Suppl. 10):S2-S7.
4. Schrag A., Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease - a community-based study. Brain 2000, 123:2297-2305.
5. Alty J.E., Clissold B.G., McColl C.D., Reardon K.A., Shiff M., Kempster P.A. Longitudinal study of the levodopa motor response in Parkinson's disease: relationship between cognitive decline and motor function. Mov Disord 2009, 24:2337-2343.
6. Nutt J.G. Levodopa-induced dyskinesia - review, observations, and speculations. Neurology 1990, 40:340-345.
7. Nutt J.G. Motor fluctuations and dyskinesia in Parkinson's disease. Parkinsonism Relat Disord 2001, 8:101-108.
8. Rascol O., Brooks D., Korczyn A., De Deyn P., Clarke C., Lang A.E. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinerole or levodopa. 056 Study Group. New Engl J Med 2000, 342:1484-1491.
9. Wickremaratchi M.M., Ben-Shlomo Y., Morris H.R. The effect of onset age on the clinical features of Parkinson's disease. Eur J Neurol 2009, 16:450-456.
10. Sharma J.C., Ross I.N., Rascol O., Brooks D. Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight. Eur J Neurol 2008, 15:493-496.
11. Walker R.W., Hand A., Jones C., Wood B.H., Gray W.K. The prevalence of Parkinson's disease in a rural area of North-East England. Parkinsonism Relat Disord 2010, 16:572-575.
12. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
13. Fahn S., Elton R.L. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-163. UPDRS Development Committee, Macmillan, New Jersey. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
14. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997, 26:353-357.
15. Folstein M.F., Folstein S.E., Mchugh P.R. Mini-mental state - practical method for grading cognitive state of patients for clinician. J Psychiatric Res 1975, 12:189-198.
16. Zigmond A., Snaith R. The hospital anxiety and depression scale. Acta Neurol Scand 1983, 67:361-370.
17. Hughes A.J., Frankel J.P., Kempster P.A., Stern G.M., Lees A.J. Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years. J Neurol Neurosurg Psychiatry 1994, 57:430-434.
18. Nutt J.G., Carter J.H., Van Houten L., Woodward W.R. Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann Neurol 1997, 42:349-355.
19. Bachmann C.G., Zapf A., Brunner E., Trenkwalder C. Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias. Eur J Neurol 2009, 16:895-901.
20. Grosset K., Bone I., Grosset D. Suboptimal medication adherence in Parkinson's disease. Mov Disord 2005, 20:1502-1506.